Background: PROSE (prosthetic replacement of ocular surface ecosystem) device is a custom-designed, corneal vaulting scleral contact lens, which is used in the treatment of irregular corneal conditions to improve vision and comfort. The present study aimed at assessing the success of the PROSE device in an Indian scenario in terms of change in quality of life and to understand the handling issues related to the device use. Methods: Thirty-two subjects with various irregular corneal conditions meeting the inclusion criteria were included in the study. Subjects were followed for three months after dispensing the PROSE device. Subjects' demographic details, high and low contrast visual acuity with habitual correction and PROSE device, Visual Function Questionnaire scores (NEI VFQ-25) and Ocular Surface Disease Index (OSDI) scores pre-and post-PROSE treatment were collected and compared. An indigenously developed questionnaire was also administered during the follow-up visit for assessing the handling-related issues faced by the subjects while using the device. Results: Forty eyes of 32 subjects were included in the study, of whom 30 reported for follow-up. The median NEI VFQ-25 score improved from 47.33 points to 77.27 points over a period of three months, which was statistically significant (p < 0.05). There was a statistically significant decrease in median OSDI score from 51.14 points to 13.63 points post-PROSE treatment (p < 0.05). Subjects reported no or very minimal handling-related difficulties associated with the use of the PROSE device. Conclusion: The PROSE treatment can be an effective mode of managing patients with irregular corneal conditions and significantly improved the vision-related quality of life of patients suffering from these conditions. The handling of the device is easy and can be mastered with adequate training.
According to WHO's global data on Visual Impairment 2010, with an estimated number of 62.619 million, India is second only to China in the number of visually impaired individuals. 1 Corneal disorders are one of the major predisposing factors of visual impairment in India. 2 Visual impairment in corneal disorders mostly results from the irregular corneal contour, which effects the regular refraction of light rays as well as loss of corneal transparency.
Irregular corneal disorders can be defined as any physiological or pathological, ocular or general body condition which causes irregular corneal surface with impairment of vision due to irregular astigmatism. 3 Irregular corneal disorders resulting from corneal ectasia and ocular surface disease are some of the major conditions which cause loss of visual acuity and other ocular symptoms. 4 The hallmarks of corneal ectatic conditions are progressive thinning of the cornea and irregular astigmatism resulting in visual impairment. Contact lenses are the primary mode of management for these conditions. With increasing severity, the lenses become less useful due to intolerability and inability to correct the irregular astigmatism. 3, 5 Ocular surface diseases can be characterised as a heterogeneous group of conditions that affect the corneal as well as the outer ocular surface including the conjunctiva, eyelids and lashes. Functional vision in patients suffering from ocular surface diseases is compromised due to the inability to open eyes because of photophobia, pain and dryness. Other common complaints of patients with ocular surface disease are redness, itching and discharge. Primarily these conditions are treated with bandage contact lenses, lubricating eye drops and oral or systemic medications. Scleral lenses are of great clinical importance in the management of irregular corneal disorders. By immersing the corneal surface in a pool of tears, the scleral lens reduces photophobia, pain and dryness. It also masks corneal surface irregularities, thereby improving the functional vision of patients. 6 The BostonSight PROSE (Prosthetic Replacement of Ocular Surface Ecosystem) device is a non-fenestrated scleral contact lens manufactured by Boston Foundation for Sight (Needham, Massachusetts, USA). The PROSE device can be customised to each individual's eye to deliver treatment effectively. It creates a sealed pool of tears over the cornea acting as a liquid bandage and regularises the corneal irregularities, which in turn improves vision and reduces the symptoms. The device is made of high oxygen-permeable RGP (rigid gas-permeable) material, which facilitates the maintenance of normal corneal physiology. An optimally fitted device should vault the cornea, while maintaining a haptic fitting relationship without excessively compressing the underlying conjunctival and scleral vessels. The device is fabricated by computerised lathes using computer-aided design and computer-aided manufacturing (CAD/CAM) technology. In previous studies, 6 the PROSE device has been reported to be successful in managing irregular corneal disorders.
Quality of life assessment is gaining importance in many fields of medical science due to the increasing emphasis on evidence-based medicine, but it is of utmost importance in the field of ophthalmology and optometry, as visual impairment can profoundly affect quality of life. 7, 8 Although Western studies have reported improved quality of life in patients managed with the PROSE device, 6,9 very little is known about the impact of PROSE treatment on the quality of life of Indian patients due to the unavailability of adequate studies. In a developing and diverse country like India, the average per capita income is significantly less compared to developed countries and the majority of the population is suburban and availing proper medical care can be forbidding for many. Moreover, high pollution rates due to accelerated industrialisation and modernisation can also confound treatment outcomes. Keeping in mind the socioeconomic, lifestyle and environmental differences between Western and Indian societies, 10 it is important to assess the success of the device to improve the quality of life in Indian patients undergoing this treatment. This study will provide an insight into quality of life in Indian patients and highlight issues related to handling of the PROSE device by Indian patients. Both are important in management of patients wearing PROSE devices.
METHODS
This prospective comparative study followed the tenets of the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of the Medical Research Foundation. The study was conducted at the contact lens clinic and department of clinical research of a tertiary eye-care hospital in southern India. Informed consent was obtained from the subjects before performing the evaluation. Thirty-two subjects (40 eyes), who were referred to the contact lens department for PROSE device trial by ophthalmologists and optometrists for the treatment of various irregular corneal conditions were included in the study. Subjects with any other associated ocular pathology apart from irregular corneal conditions and any surgery within three months from the date of dispensing the device were excluded from the study.
Initial visit
The PROSE device fitting followed a defined protocol which included initial fitting assessment with trial devices and slitlamp examination three and six hours post-device wear. The fitting assessment was done over two days and the final device was fabricated using spline-based CAD/CAM lathes, which allowed any customisation needed for obtaining an optimal fitting on individual eyes. The lens material used for fabricating the device was Equalens II (Dk 85), which is a high oxygen-permeable RGP material. 6 Once the final device arrived, each subject was scheduled for a dispensing visit. Lowcontrast visual acuity (LCVA) with 25 per cent contrast charts and high-contrast visual acuity (HCVA) were measured with the subject's habitual correction and with the PROSE device using illuminated Early Treatment Diabetic Retinopathy Study (ETDRS) charts. A trained interviewer administered two questionnaires, first the 25-item National Eye Institute Vision Functioning Questionnaire (NEI VFQ-25) and then Ocular Surface Disease Index (OSDI). Both the questionnaires are validated, standardised and widely used instruments for the assessment of quality of life and visual functions, respectively, in the Indian population.
11-14 A higher score obtained in NEI VFQ-25 suggests better quality of life and a lower score in OSDI suggests less ocular surface disease severity. The questionnaires were administered while the subjects were wearing their habitual correction. There was no time limit for answering the questions. There was a gap of five minutes after the completion of the first questionnaire and administration of the second. The scoring of the questionnaires was done according to the guidelines provided. The subjects were then given instructions for proper handling of the device, including insertion, removal and cleaning. Sessions were repeated until subjects were able to master these procedures. Subjects were advised to gradually increase the wearing hours till they were comfortable with the device.
Follow-up visit
The subjects attended again after three months, provided a desirable fitting and vision were obtained with the final device. During this visit, HCVA and LCVA were measured with the PROSE device. Slitlamp examination was done to assess the anterior segment and lens fitting. NEI VFQ-25 and OSDI questionnaires were readministered by a trained interviewer following slitlamp examination. The data and scores of the initial visit and follow-up visit were analysed and compared.
The questionnaire for handling of PROSE device has 13 items. This questionnaire was developed to assess handling, routine care and maintenance and wearing comfort of the PROSE device. To the best of our knowledge, no pre-validated questionnaire was available for this purpose. The questions were based on focus group discussions with senior optometrists in the contact lens clinic. The drafted questionnaire was circulated among 10 contact lens practitioners and 10 non-contact lens practitioners. They were asked to read and interpret the questions in the questionnaire. Those questions that had no difference in opinion in the interpreted meaning among the practitioners were included in the final questionnaire. If any difference was perceived, the questions were reframed till no difference was evident. Each question has five options. Subjects were asked to choose the option that best represented their condition (Appendix 1). The responses of the subjects were analysed and are presented in the study. SPSS Inc., Chicago, Illinois, USA). The test for normality was performed using Shapiro-Wilk test. The test distribution was non-parametric. Descriptive statistics for the data set were performed and represented as median and interquartile range (IQR). Wilcoxon's signed-rank test was performed to compare the median difference in HCVA with habitual correction and with the PROSE device. Median deference in LCVA with habitual correction and with the PROSE device was also compared using Wilcoxon's signed-rank test. The scores obtained with NEI VFQ-25 and OSDI questionnaires pre-and post-PROSE treatment were also compared using Wilcoxon's signed-rank test. Type I error of five per cent was taken as statistically significant. Proportions of different responses obtained through the handling questionnaire are presented in the form of pie charts.
RESULTS
In the study, 40 eyes of 32 eligible subjects were included. The median (IQR) age of the study group was 26 AE 13 years ranging from 18 to 48 years. The male : female ratio was 18 : 14. The reason for fitting the PROSE device was ocular surface disease in 17 eyes and corneal ectatic conditions in 23 eyes. Eight subjects were binocular PROSE users, while the rest were wearing the device in one eye. The median diameter of the PROSE devices prescribed during the study was 19.5 AE 1 mm, which ranged from 15.5 mm to 19.5 mm. The majority of the subjects in the study were prescribed with a large-diameter PROSE devices (19.5 mm). One subject was prescribed with a smaller diameter device (15.5 mm) because of reduced palpebral aperture size secondary to symblepharon formation.
Habitual visual correction
The most common habitual correction for vision in the study population was glasses (14 eyes). Other modes of vision correction were RGP (eight eyes), Rose K (four eyes), RGP piggyback (two eyes), Rose K piggyback (one eye) and soft contact lenses (one eye). A few subjects in the study population did not use any mode of vision correction (10 eyes).
Comparison of HCVA and LCVA with habitual correction and PROSE device HCVA with habitual correction and with the PROSE device were compared using Wilcoxon's signed-rank test. A statistically significant difference was observed where the median (IQR) HCVA with habitual correction improved from 0.60 AE 0.70 log-MAR to 0.20 AE 0.18 logMAR with the PROSE device (p = 0.0001). LCVA with habitual correction and with the PROSE device were also compared using Wilcoxon's signed-rank test. The median (IQR) LCVA with habitual correction improved from 0.95 AE 0.50 logMAR to 0.30 AE 0.30 logMAR with the PROSE device and was statistically significant (p = 0.0001).
Comparison of HCVA and LCVA with PROSE device during initial visit and follow-up visit
Of the 32 eligible subjects, 30 were available for follow-up. No statistically significant difference was observed between the HCVA during the initial visit and during the follow-up visit (p = 0.381). Also, no statistically significant difference was observed between LCVA during initial visit and the follow-up visit (p = 0.170).
Quality of life assessment with NEI VFQ-25 questionnaire preand post-PROSE treatment for all subjects
Of the 32 subjects, 30 completed the NEI VQF-25 questionnaire during the initial visit (pre-PROSE treatment) as well as on the follow-up visit (post-PROSE treatment). Only eight subjects (25 per cent) were driving cars during the study period and other 22 (75 per cent) were non-drivers. Due to the large proportion of non-drivers in the study population, the subscale 'Driving' was excluded from the calculation of the composite quality of life score. A statistically significant improvement in median scores was observed in all the subscales of NEI VFQ-25 post-PROSE treatment (Figure 1 ). 
Handling of PROSE device
An indigenously developed questionnaire was used to understand the day-to-day issues faced by the subjects undergoing the PROSE treatment. The questionnaire was administered during the follow-up visit. The responses obtained from the subjects are presented here (Figures 2 to 4) .
DISCUSSION
This prospective comparative study reports the effect of PROSE treatment on the quality of life of patients suffering from complex corneal disorders. The PROSE device intends to improve vision by forming a clear fluid reservoir between the device and the corneal anterior surface, which regularises the irregular corneal contour.
Visual correction with PROSE device
There are various studies reporting on improved visual acuity with the PROSE device as compared to visual acuity with other visual correction devices ( Table 2 ).
The current study was found to be in agreement with these studies.
In addition, the present study also compared LCVA with the habitual correction of the subjects and with the PROSE device. A statistically significant improvement was found in the LCVA with the PROSE device and habitual correction of the subjects. The irregular corneal conditions degrade LCVA by increasing higher-order aberrations. Many day-to-day activities like driving, reading, watching television and climbing stairs during dim light conditions require good LCVA. 17 The PROSE device helps in reducing these higher order aberrations by regularising the corneal surface, which in turn, increases the LCVA of the subjects. No difference was observed in both HCVA and LCVA between initial and follow-up visits. Future studies with longer follow-up periods are indicated to evaluate the change in visual acuity with the use of the PROSE device and to evaluate changes, if any, due to the device surface and other factors.
Change in quality of life with PROSE treatment
An overall statistically significant improvement was found in all the subscales as well as in the composite score of NEI VFQ-25, which suggests that the quality of life of 6 conducted a similar study in 2009 and reported statistically significant improvement in quality of life in subjects with PROSE treatment. Although they included subjects with irregular corneas, the improvement in score with the treatment was 20.8 points. In the present study, the improvement in the composite score of NEI VFQ-25 with the PROSE treatment was found to be 29.94 points ( Table 3) . One possible reason behind the increased improvement in quality of life in the present study can be more clinically severe conditions treated in the present study with the PROSE treatment compared with the previous study. A similar study by Baran and colleagues 9 also reported improved quality of life with the PROSE treatment. According to the study conducted by Dimit and colleagues, 18 an improvement in quality of life scores with the PROSE device was obtained in subjects with dry eye disease (ocular surface diseases) as well as in subjects with refractive irregular corneas, but failed to gain statistical significance.
Scales
The quality of life change with the PROSE device was also assessed separately in subjects with ocular surface disease and corneal ectatic conditions in the present study. Both the groups showed a statistically significant improvement in quality of life with the PROSE treatment; however, the improvement was more in the ocular surface diseases group than in the corneal ectatic conditions group, which can most likely be explained by the fact that the subjects of the former group are more symptomatic due to ocular surface imperfections combined with poor visual acuity and the PROSE device with its therapeutic and optical effect helps in reducing much of these symptoms, resulting in better quality of life.
Change in OSDI with PROSE treatment
The OSDI questionnaire was used in the study for the assessment of ocular symptoms related to dry eye and the impact of these symptoms on the vision-related functioning of an individual. The overall median OSDI score for subjects with irregular conditions was found to be 51.14 during the initial visit. According to Schiffman and colleagues, 13 a score of 36 and above 
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represents severe dry eyes. In the present study, a much higher score was obtained, which suggests that most of the subjects in this study had severe dry eyes and related symptoms. With the PROSE treatment the OSDI scores reduced to 13.63 points, suggesting improvement in visual functions and reduction in ocular symptoms with the treatment. The OSDI scores were found to be higher in the ocular surface diseases group and showed more improvement with the PROSE treatment than in the corneal ectatic conditions group. Although the samples in the two groups were small, the PROSE treatment appears to be more effective in improving visual function and reducing symptoms in the ocular surface diseases group than in the corneal ectatic conditions group.
Handling of PROSE devices
Being a scleral lens, the PROSE device is much larger compared to conventional contact lenses. Because of the larger size, subjects using the device may experience difficulties in regular insertion and removal of the device. Regarded as a treatment option rather than just a contact lens, the device demands extra care and maintenance for proper functioning. 19 In this study, handling-related issues experienced by the subjects using the PROSE device were assessed.
ISSUES RELATED TO WEARING AND REMOVAL OF THE PROSE DEVICE
All subjects were given adequate training for proper insertion and removal before dispensing the device. According to this study, the majority of the subjects felt that insertion of the device was easy and so they were able to wear the device in fewer trials. These subjects had better visual acuity and were younger in age than those who felt the procedure was difficult and needed more trials for insertion. Similarly, removal of the device was reported to be easy by most of the subjects and needed fewer trials. Some subjects felt removal of the device was difficult and took more trials for correct removal due to difficulty in placing the plungers in the correct position. More training is recommended for those who feel the insertion and removal procedures are difficult.
MAINTENANCE OF THE DEVICE
Cleaning of the device is critical and requires extra care because of the size of the device, fluid ventilation and chances of breakage in case of improper handling. The solutions needed for proper cleaning and disinfection of the device are specifically prescribed and may not be commonly available at all places. In this study, the majority of the subjects reported that the cleaning process of the device was easy but faced difficulties in obtaining the recommended cleaning solutions. A few subjects in the study were found to be using soft contact lens solutions and not the recommended ones due to unavailability. The Table 2 . Results of present study and previous studies comparing visual acuity with the PROSE (prosthetic replacement of ocular surface ecosystem) device and habitual correction Quality of life PROSE device Bhattacharya and Mahadevan cleaning and disinfecting solutions for gas permeable lenses are not widely available in India. Because of the low gas permeable lens fitting rate in India, 20 manufacture of these recommended solutions is limited, as the market for these solutions is very small and all retailers prefer not to have these in stock. As multipurpose solutions and intensive cleaners are necessary for proper maintenance of the device but are not available widely, subjects should be advised to stock enough cleaning solutions from the clinic itself or get the solutions directly from the manufacturers, till the next follow-up. The majority of the subjects in the study felt travelling with the device was difficult because of the increased care needed during that time. These subjects should be reassured and the importance of proper care and maintenance of the device, while travelling should be emphasised. In this study only a few subjects were found to be worrying about dropping the device. Constant fear of dropping the device may limit confident handling. Subjects worrying about dropping the device can be advised to carry out the procedures over some soft surfaces like towels.
WEARING COMFORT OF PROSE DEVICES
In the present study, none of the subjects reported difficulty in moving the eyes with the device in situ. This suggests that although the device is larger, it does not hamper eye movements. Wearing time of the scleral lenses is considered as a measure of success of the treatment. It is expected that lenses should provide better vision and comfort for a longer duration and the same applies for the PROSE device. In the study by Rathi and colleagues, 21 the average wearing period of the device was nine hours. According to the study by Severinsky and colleagues, 22 a continuous wearing period of six hours and more can be considered as a successful scleral lens treatment. Most of the subjects in the present study were found to be wearing the device for more than six hours continuously. Very few subjects failed to attain the continuous wearing period of six hours and had to remove the lenses more frequently. The possible reason for the reduced wearing period and need for frequent removal of the device in these subjects may be the increased severity of the ocular condition, especially in patients with ocular surface disease due to the need for ocular ointments and gels at regular intervals. The majority of the subjects included in the study reported to be comfortable with the device and felt more confident while performing daily works wearing the device.
CONCLUSION
Improved visual outcome and comfort can be obtained with the PROSE device in subjects with irregular corneal conditions. Increased NEI VFQ-25 scores reveal improved quality of life in patients after the PROSE treatment. Increased ocular comfort after PROSE treatment is revealed by the decreased OSDI score. PROSE treatment is an effective mode to manage patients with irregular corneas. Handling and maintenance of the device, although found to be easy, necessitates proper instructions and repeated patient training. 
